Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
公司代碼HLN
公司名稱Haleon PLC
上市日期Jul 18, 2022
CEOMcnamara (Brian)
員工數量- -
證券類型Depository Receipt
年結日Jul 18
公司地址Building 5, First Floor
城市WEYBRIDGE
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United Kingdom
郵編KT13 0NY
電話441932822000
網址https://www.haleon.com/
公司代碼HLN
上市日期Jul 18, 2022
CEOMcnamara (Brian)